DJO Global - ENOV Short-Term Debt to Capital

ENOV (Enovis Corporation) - company brandmark

The available price action for Enovis Corporation (ENOV) reflects the dynamics of an asset whose profits are based on stable demand for surgical restoration and an aging population, as confirmed by the 0.05 metric. Enovis Corporation (ENOV) minimizes risks through the production of rehabilitation tools and implants for athletes. The business's operational resilience is ensured by an extensive network of modern plants that guarantee supply reliability worldwide.

ENOV - Enovis Corp Short-Term Debt to Equity Ratio over the range 04/28/2023 - 11/01/2026
Brand item of Enovis

The stability of Enovis Corporation (ENOV) relies on attracting leading orthopedic engineers and advancing R&D, which necessitates precise liquidity management. This metric correlates liabilities with maturities of up to one year against equity, allowing investors to assess default risk and the cost of financial stability via the short-term debt-to-equity ratio on the GURU.Markets platform.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|insulet.com (PODD) - Current Liabilities to Capital|Zimmer Biomet Holdings - Short-Term Debt to Capital|The Cooper Companies, Inc. (COO) - Short-Term Debt to Equity Ratio|ALGN: Short-Term Debt to Capital|GMED - Short-Term Debt to Capital Coefficient|TMDX (TransMedics Group Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital atecspine.com|Short-Term Debt to Equity Artivion (AORT)|Short-Term Debt to Equity IART (Integra LifeSciences Corp)|Short-Term Debt to Capital ESTA (Motiva)|Short-Term Debt to Capital Coefficient iLet Bionic Pancreas (BBNX)|IRMD: Short-Term Debt to Equity Ratio|Current Liabilities to Equity EMBC|TNDM: Short-Term Debt to Capital|Current Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Short-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Short-Term Debt to Equity Ratio|Carlsmed Corp - Short-Term Debt to Capital|Current Liabilities to Capital RxSight Ophthalmic|CLPT: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Short-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital OBIO|Short-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Short-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Short-Term Debt to Equity|XTNT: Short-Term Debt to Equity|NMTC (NeuroOne Corp) - Short-Term Debt to Equity Ratio|Modular Medical, Inc. - Ratio of Short-Term Indebtedness to Capital|MYO (Myomo, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital envoymedical.com COCH|Short-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Short-Term Indebtedness to Equity|Sintx Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Current Liabilities to Equity BBLG (Bone Biologics Corp.)|Short-Term Debt to Equity Axonics Modulation Technologies|Short-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO